Cargando…

Anxiety and Depression in COVID Survivors - A Cross-Sectional Study Six Months Past the Acute Illness

Background Studies exploring the long-term psychiatric sequelae of COVID-19 are sparse. We aimed to assess depression and anxiety six months after recovery and the association between disease severity and psychiatric sequelae. Material and methods Our study was a comparative study conducted on COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avula, Vijaya Chandra R, Amalakanti, Sridhar, M, Shashidhara, Fasiha, Afreen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475854/ https://www.ncbi.nlm.nih.gov/pubmed/37671223 http://dx.doi.org/10.7759/cureus.42971

Ejemplares similares

Six months into the war: a first-wave study of stress, anxiety, and depression among in Ukraine
por: Kurapov, Anton, et al.
Publicado: (2023)

The Development of Illness Anxiety Disorder in a Patient After Partial Thyroidectomy
por: Kancherla, Neeraj, et al.
Publicado: (2022)

Prevalence Rates and Predictors of Generalized Anxiety Disorder Symptoms in Residents of Fort McMurray Six Months After a Wildfire
por: Agyapong, Vincent I. O., et al.
Publicado: (2018)

Depression, anxiety and post-traumatic growth among COVID-19 survivors six-month after discharge
por: Xiao, Xin, et al.
Publicado: (2022)

The effect of anxiety and depression on the health-related quality of life of severe acute pancreatitis survivors: structural equation modeling approach
por: Wang, Xueting, et al.
Publicado: (2023)

The Role of Illness-Related Beliefs in Depressive, Anxiety, and Anger Symptoms: An On-line Survey in Women With Hypothyroidism
por: Pankowski, Daniel, et al.
Publicado: (2021)

A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
por: Sathiyamoorthi, Sathiyanarayanan, et al.
Publicado: (2023)

Anxiety, Depression, and Satisfaction With Life Among College Students in China: Nine Months After Initiation of the Outbreak of COVID-19
por: Xiao, Pei, et al.
Publicado: (2022)

Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up
por: Gramaglia, Carla, et al.
Publicado: (2022)

Meditative Movement for Depression and Anxiety
por: Payne, Peter, et al.
Publicado: (2013)

Do Parent Mental Illness and Family Living Arrangement Moderate the Effects of the Aussie Optimism Program on Depression and Anxiety in Children?
por: Cheng, Maryanne, et al.
Publicado: (2018)

COVID-19 pandemic’s impact on networks of depression and anxiety in naturalistic transdiagnostic sample of outpatients with non-psychotic mental illness
por: Kim, Shin Tae, et al.
Publicado: (2023)

Anxiety and Depression in Patients With Pulmonary Arterial Hypertension in Northwest China: A Cross-Sectional Study
por: Zhang, Juxia, et al.
Publicado: (2022)

Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China
por: Chen, Mengting, et al.
Publicado: (2021)

Anxiety in the Medically Ill: A Systematic Review of the Literature
por: Romanazzo, Sara, et al.
Publicado: (2022)

Placebo Effect in the Treatment of Depression and Anxiety
por: Kirsch, Irving
Publicado: (2019)

Post-traumatic Stress Disorder Symptoms and Quality of Life of COVID-19 Survivors at 6-Month Follow-Up: A Cross-Sectional Observational Study
por: Huang, Liqun, et al.
Publicado: (2022)

Depression, Anxiety and Their Correlates Among Patients With HIV in South Ethiopia: An Institution-Based Cross-Sectional Study
por: Duko, Bereket, et al.
Publicado: (2019)

A Cross-Sectional Study on the Psychological Impact of Stress, Anxiety and Depressive Symptoms in COVID-19 Patients
por: Jakhar, Kiran, et al.
Publicado: (2022)

Anxiety and depression among patients with non-tuberculous mycobacterial disease in Shanghai: a cross-sectional study
por: Ni, Sikang, et al.
Publicado: (2023)

Depressive Symptom Network Associated With Comorbid Anxiety in Late-Life Depression
por: An, Min Ho, et al.
Publicado: (2019)

Mental Health of COVID-19 Survivors at 6 and 12 Months Postdiagnosis: A Cohort Study
por: Huang, Xin, et al.
Publicado: (2022)

Editorial: Traditional Chinese medicine for depression and anxiety
por: Yang, Xinjing, et al.
Publicado: (2023)

Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress
por: Kucukkarapinar, Melike, et al.
Publicado: (2022)

Association between depression or anxiety symptoms and immune-inflammatory characteristics in in-patients with tuberculosis: A cross-sectional study
por: Liu, Xiangmin, et al.
Publicado: (2022)

Caffeine Consumption and Depression, Anxiety, and Stress Levels Among University Students in Medina: A Cross-Sectional Study
por: Makki, Nadir M, et al.
Publicado: (2023)

Effects of Polyphenol Supplementations on Improving Depression, Anxiety, and Quality of Life in Patients With Depression
por: Lin, Kelly, et al.
Publicado: (2021)

Illness Anxiety Disorder: A Case Report and Brief Review of the Literature
por: Espiridion, Eduardo D, et al.
Publicado: (2021)

Magnitude and factors associated with anxiety and depression among patients with breast cancer in central Ethiopia: A cross-sectional study
por: Belay, Winini, et al.
Publicado: (2022)

Depression, anxiety and stress, during COVID-19 pandemic among midwives in ethiopia: A nationwide cross-sectional survey
por: Kassahun, Eskeziaw Abebe, et al.
Publicado: (2022)

Depression and anxiety among people with hypertension on follow-up in Eastern Ethiopia: A multi-center cross-sectional study
por: Abdisa, Lemesa, et al.
Publicado: (2022)

Frequency of Depression and Anxiety Symptoms in Surgical Hospitalized Patients
por: Mirani, Shahid H, et al.
Publicado: (2019)

Depression and Anxiety as a Risk Factor for Myocardial Infarction
por: Mal, Kheraj, et al.
Publicado: (2019)

The Prevalence of Anxiety and Depression Symptoms in Obstructive Sleep Apnea
por: Akberzie, Wahida, et al.
Publicado: (2020)

Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
por: Hu, Shurong, et al.
Publicado: (2021)

The Use of Safflower (Carthamus tinctorius) in Treating Depression and Anxiety
por: Albaiz, Asma S
Publicado: (2022)

Anxiety and Depression Comorbidities in Moroccan Patients With Breast Cancer
por: El kherchi, Ouassil, et al.
Publicado: (2021)

Depression, anxiety, insomnia and interleukins in the early postpartum period
por: Drozdowicz-Jastrzębska, Ewa, et al.
Publicado: (2023)

Aberrant Resting-State Cerebellar-Cerebral Functional Connectivity in Methamphetamine-Dependent Individuals After Six Months Abstinence
por: Li, Xiaotong, et al.
Publicado: (2020)

Ceremonial Ayahuasca in Amazonian Retreats—Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study
por: Ruffell, Simon G. D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1809kc9vuu364ljj35smrsd8b